Capital Research Global Investors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172M | Sell |
3,988,298
-679,104
| -15% | -$29.3M | 0.03% | 235 |
|
|
2025
Q1 | $161M | Buy |
4,667,402
+1,140,655
| +32% | +$39.4M | 0.04% | 243 |
|
|
2024
Q4 | $96.8M | Buy |
3,526,747
+912,439
| +35% | +$25M | 0.02% | 304 |
|
|
2024
Q3 | $66.6M | Buy |
2,614,308
+402,223
| +18% | +$10.2M | 0.01% | 316 |
|
|
2024
Q2 | $56M | Hold |
2,212,085
| – | – | 0.01% | 326 |
|
|
2024
Q1 | $68.4M | Buy |
2,212,085
+1,111,975
| +101% | +$34.4M | 0.02% | 318 |
|
|
2023
Q4 | $44.4M | Hold |
1,100,110
| – | – | 0.01% | 329 |
|
|
2023
Q3 | $27.6M | Buy |
+1,100,110
| New | +$27.6M | 0.01% | 358 |
|